Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
LINC01345 is a human long intergenic non-protein coding RNA gene, transcribed into a non-coding RNA molecule that does not encode a protein. This lincRNA belongs to the class of non-coding RNAs that are longer than 200 nucleotides and do not overlap known protein-coding genes. While the biological role of LINC01345 remains uncharacterized, lincRNAs in general are implicated in fine-tuning the expression of nearby genes, chromatin structure modulation, and various levels of gene regulation important for tissue specificity and development. Functional characterization and disease associations for LINC01345 have not yet been reported in the scientific literature or gene databases. Emerging research on lincRNAs suggests broad regulatory roles and possible future relevance in cancer and other diseases, but there is no specific evidence and no known drugs acting on LINC01345 to date.
Not applicable; there are no drugs known to act directly on LINC01345 or lincRNAs as a class.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Long intergenic non-protein coding RNA 1345 (LINC01345).